Freestone-Grove-Partners-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
568
Total Value
9707259284
Accession Number
0001172661-25-002408
Form Type
13F-HR
Manager Name
Freestone-Grove-Partners-Lp
Data Enrichment
98% identified
556 identified12 unidentified

Holdings

568 positions • $9.7B total value
Manager:
Search and click to pin securities to the top
Page 29 of 29
Stoke Therapeutics, Inc.
Shares:14.8K
Value:$98.3K
% of Portfolio:0.0% ($98.3K/$9.7B)
NOVAVAX INC
Shares:14.1K
Value:$90.3K
% of Portfolio:0.0% ($90.3K/$9.7B)
Brookdale Senior Living Inc.
Shares:12.9K
Value:$80.5K
% of Portfolio:0.0% ($80.5K/$9.7B)
ARDELYX, INC.
Shares:16.1K
Value:$78.9K
% of Portfolio:0.0% ($78.9K/$9.7B)
QuantumScape Corp
Shares:15.7K
Value:$65.3K
% of Portfolio:0.0% ($65.3K/$9.7B)
Hanesbrands Inc.
Shares:10.8K
Value:$62.3K
% of Portfolio:0.0% ($62.3K/$9.7B)
FTAI Infrastructure Inc.
Shares:12.6K
Value:$57.0K
% of Portfolio:0.0% ($57.0K/$9.7B)
IOVANCE BIOTHERAPEUTICS, INC.
Shares:15.5K
Value:$51.5K
% of Portfolio:0.0% ($51.5K/$9.7B)